Oxygenta Pharmaceutical share news, announcements and annual reports
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹46.77.
28 Oct: open ₹45.85, high ₹48.25, low ₹45.85
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹177 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 8,579
Oxygenta Pharmaceutical has 489 announcements on record, routine notices left out; 1 in the 30 days to 29 Oct 2026, the latest on 1 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Oxygenta Pharmaceutical quarterly results
The board met on 27 Jul 2026 to consider quarterly results
Notice filed 22 Jul 2026
Oxygenta Pharmaceutical annual reports, presentations and earnings calls
The company's own documents, latest first.Oxygenta Pharmaceutical financials, year by year
Annual reports26
- Annual report, year to Mar 202630 Jul 2026
- Annual report, year to Mar 202528 Aug 2025
- Annual report, year to Mar 20247 Sep 2024
- Annual report, year to Mar 20237 Sep 2023
- Annual report, year to Mar 20225 Sep 2022
21 earlier reports
- Annual report, year to Mar 20219 Dec 2021
- Annual report, year to Mar 20208 Dec 2020
- Annual report, year to Mar 201910 Sep 2019
- Annual report, year to Mar 201820 Oct 2018
- Annual report, year to Mar 201712 Oct 2017
- Annual report, year to Mar 201614 Oct 2016
- Annual report, year to Mar 20151 Dec 2015
- Annual report, year to Mar 2014Filing day not known
- Annual report, year to Mar 201314 Jan 2014
- Annual report, year to Mar 201214 Jan 2014
- Annual report, year to Mar 201114 Jan 2014
- Annual report, year to Mar 201014 Jan 2014
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2001Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Oxygenta Pharmaceutical share news and announcements
Newest first. Page 1 of 10.
Oct 2026
1 Oct · Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Purchase Of Land
Aug 2026
21 Aug · Meeting
Jul 2026
30 Jul · Meeting
27 Jul · Management
27 Jul · Results
27 Jul · Results
22 Jul · Board meeting
Meeting on 27 Jul 2026: quarterly results
May 2026
23 May · Results
19 May · Board meeting
Meeting on 23 May 2026: audited results
Apr 2026
27 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Feb 2026
20 Feb · Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
Jan 2026
30 Jan · Board meeting
Meeting on 4 Feb 2026: quarterly results
Dec 2025
11 Dec · Intimation Under Regulation 30 The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations') To Stock Exchanges Regarding Approval Of The Shareholders For Reclassification Of Person(S) Forming Part Of The Promoter/ Promoter Group From 'Promoter/ Promoter Group Category' To 'Public Category' Shareholder(S) Regulation 31A Of The SEBI Listing Regulations.
11 Dec · Meeting
11 Dec · Meeting
11 Dec · Meeting
Nov 2025
11 Nov · Meeting
7 Nov · Results
3 Nov · Board meeting
Meeting on 7 Nov 2025: quarterly results
Oct 2025
22 Oct · Disclosure Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Sep 2025
19 Sep · Meeting
Aug 2025
29 Aug · Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of The Promoter / Promoter Group From 'Promoter Group Category To Public Category' Shareholder Of The Company Pursuant To Regulation 31A Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')
25 Aug · Board meeting
Meeting on 25 Aug 202525 Aug · Intimation Under Regulation 31A Of The SEBI (LODR) Regulations, 2015 For Reclassification From 'Promoter /Promoter Group' To 'Public'
25 Aug · Board meeting
19 Aug · Intimation Of Receipt Of Request Applications From Promoters For Reclassification In Accordance With Regulation 31A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations, 2015')
19 Aug · Management
18 Aug · Management
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 28 Jul 2026Board or managers changeddown 2.15%−2.0 pts vs Nifty 500market median 0.0% · five sessions −3.3% (−6.1 pts vs Nifty 500) · volume 1.6× usual · The announcement
- 25 May 2026Board or managers changeddown 2.98%−4.2 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−5.0 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 10 Nov 2025Board or managers changeddown 3.33%−3.7 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−7.0 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 19 Aug 2025Board or managers changeddown 4.59%−5.2 pts vs Nifty 500market median 0.0% · five sessions −7.1% (−7.6 pts vs Nifty 500) · volume 1.7× usual · The announcement
- 18 Aug 2025Board or managers changeddown 1.91%−3.0 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−10.7 pts vs Nifty 500) · volume 6.6× usual · The announcement
- 23 Jun 2025Board or managers changedup 3.17%+3.3 pts vs Nifty 500market median 0.0% · five sessions +5.5% (+3.0 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 3 Oct 2024Board or managers changedup 5.00%+7.1 pts vs Nifty 500market median 0.0% · five sessions +20.4% (+23.2 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 15 Feb 2024Board or managers changeddown 2.03%−2.6 pts vs Nifty 500market median 0.0% · five sessions +4.8% (+3.7 pts vs Nifty 500) · volume 1.5× usual · The announcement
- 5 Sep 2023Board or managers changed0.00%−0.4 pts vs Nifty 500market median 0.0% · five sessions +2.2% (−0.5 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 14 Aug 2023Board or managers changeddown 4.99%−4.8 pts vs Nifty 500market median 0.0% · five sessions −18.1% (−18.0 pts vs Nifty 500) · volume 0.7× usual · The announcement
5 earlier announcements
- 3 Jul 2023Board or managers changeddown 2.53%−3.1 pts vs Nifty 500market median 0.0% · five sessions +3.7% (+2.9 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 8 Dec 2021Board or managers changeddown 4.89%−6.5 pts vs Nifty 500market median 0.0% · five sessions −3.9% (−5.3 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 30 Apr 2019Board or managers changed–market median 0.0% · volume 0.0× usual · The announcement
- 16 Jan 2018Board or managers changeddown 0.43%0.0 pts vs Nifty 500market median 0.0% · five sessions +19.5% (+17.4 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 6 Mar 2017Board or managers changed–market median 0.0% · volume 0.3× usual · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Earnings per share, continuing businesses | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |
| Earnings per share, continuing businesses | Quarter to Dec 2024 | Standalone | 1.07 | −1.07 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |
| Diluted earnings per share, continuing businesses | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |
| Diluted earnings per share, continuing businesses | Quarter to Dec 2024 | Standalone | 1.12 | −1.12 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |
| Earnings per share | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |
| Earnings per share | Quarter to Dec 2024 | Standalone | 1.07 | −1.07 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |
| Diluted earnings per share | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |
| Diluted earnings per share | Quarter to Dec 2024 | Standalone | 1.12 | −1.12 | −200.0% | 15 Feb 2025 | 17 Feb 2025 |